Sci-B-Vac

BIOLOGICAL2 trials

Sponsors

Tel-Aviv Sourasky Medical Center, Soroka University Medical Center

Conditions

HIVInflammatory Bowel Disease

Unknown Phase

Efficiency of the Hepatitis B Sci-B-Vac Vaccine in HIV Positive Patients

Tel-Aviv Sourasky Medical CenterHIV

Start: 2011-11-30End: 2013-11-30Target: 100Updated: 2011-10-06

Hepatitis B Vaccine in Patients With Inflammatory Bowel Disease

CompletedNCT01531075

Soroka University Medical CenterInflammatory Bowel Disease

Start: 2012-04-30End: 2016-08-31Updated: 2020-04-21